John A Stalfort Iii Taysha Gene Therapies, Inc. (TSHA) insider trading activity

John A Stalfort Iii is of Taysha Gene Therapies, Inc.. Currently has a direct ownership of 1.1 Million shares of TSHA, which is worth approximately $2.71 Million. The most recent transaction as insider was on May 29, 2024, when has been sold 49,220 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.1M

0% 3M change

4.69% 12M change

Total Value Held $2.71 Million

John A Stalfort III Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 29 2024	BUY Grant, award, or other acquisition	-	49,220 Added 4.29%	1,098,601 Common Stock
Aug 16 2023	BUY Bona fide gift	-	50,000 Added 4.55%	1,049,381 Common Stock
Aug 16 2023	BUY Open market or private purchase	$350,000 $0.9 p/Share	388,889 Added 28.01%	999,381 Common Stock

Also insider at

ABOS

Acumen Pharmaceuticals, Inc. Healthcare

Director

VRCA

Verrica Pharmaceuticals Inc. Healthcare

Director

JAS